Dr. Goldberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Bwh, Pbb Clinics-3
Boston, MA 02115Phone+1 617-732-7420Fax+1 617-732-7421
Summary
- Dr. Hilary Goldberg is a pulmonologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital, Brigham and Women's Faulkner Hospital, and Spaulding Hospital for Continuing Medical Care Cambridge. She received her medical degree from New York University Grossman School of Medicine and has been in practice 23 years. She specializes in interstitial lung disease and lung transplantation and is experienced in transplant pulmonology and critical care medicine. She has more than 90 publications and over 500 citings.
Education & Training
- University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2005
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1996 - 1999
- New York University School of MedicineClass of 1996
Certifications & Licensure
- MA State Medical License 1998 - 2026
- NH State Medical License 2024 - 2024
- ME State Medical License 2020 - 2021
- MN State Medical License 2004 - 2005
- TX State Medical License 2000 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 638 citationsEfficacy and safety of sirolimus in lymphangioleiomyomatosis.Francis X. McCormack, Yoshikazu Inoue, Joel Moss, Lianne G. Singer, Charlie Strange
The New England Journal of Medicine. 2011-04-27 - 35 citationsThe design and rationale of the Trail1 trial: A randomized double-blind phase 2 clinical trial of pirfenidone in rheumatoid arthritis-associated interstitial lung diseaseJoshua J. Solomon, Sonye K. Danoff, Hilary J. Goldberg, Felix Woodhead, Martin Kolb
Advances in Therapy. 2019-09-12 - 58 citationsSafety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-contr...Joshua J Solomon, Sonye K Danoff, Felix A Woodhead, Shelley Hurwitz, Rie Maurer
The Lancet. Respiratory Medicine. 2023-01-01
Press Mentions
- When Is a Transplant Worth It?May 4th, 2019
- Hepatitis C-infected Hearts and Lungs Safely TransplantedApril 4th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: